DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

UPDATE: Cantor Fitzgerald On Aimmune Therapeutics Believes 'that PALFORZIA may see robust early adoption, transforming PA treatment by informed allergists who view the risk-reward as favorable for higher-risk/motivated patient/caregiver cohorts'

Benzinga · 02/03/2020 12:23